We are live on ! Find out more
INFI

Infinity Pharmaceuticals, Inc.
INFI

Delisted

INFI was delisted on the 13th of September, 2023.

Back to rankings

3 hedge funds and large institutions have $2.9K invested in Infinity Pharmaceuticals, Inc. in 2023 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 44 closing their positions.

New
Increased
Maintained
Reduced
Closed

22.35% less ownership

Funds ownership: 22.35% → 0% (-22%)

93% less funds holding

Funds holding: 45 → 3 (-42)

95% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 44

100% less capital invested

Capital invested by funds: $4.23M → $2.9K (-$4.23M)

Holders
3
Holders Change
-42
Holders Change %
-93.33%
% of All Funds
0.05%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
–
Reduced
–
Closed
44
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
XT
XTX Topco
Cayman Islands
+$24K
2
HCM
Highlander Capital Management
New Jersey
+$464

Top Sellers

Rank Fund Capital Flow
1
BI
BVF Inc
California
-$1.34M
2
Vanguard Group
Vanguard Group
Pennsylvania
-$838K
3
SFM
Sphera Funds Management
Israel
-$311K
4
BlackRock
BlackRock
New York
-$308K
5
CC
Carlson Capital
Texas
-$274K

INFI Hedge Fund Activity: Q3 2023 in Review

3 of the 6,311 institutional investors tracked by Wall St. Rank reported a position in Infinity Pharmaceuticals, Inc. (INFI) for Q3 2023, worth a combined $2.9K — down 100% from $4.23M a quarter earlier.

Sellers outnumbered buyers: 44 funds closed out of INFI and 2 opened new positions — a net loss of 42 holders — while 0 trimmed existing stakes and 0 added.

The largest buyer was XTX Topco, opening a new position worth an estimated $24K. The largest seller was BVF Inc, exiting entirely with an estimated $1.34M sold.

  • 3 institutional investors held Infinity Pharmaceuticals, Inc. (INFI) as of Q3 2023, down from 45 in Q2 2023.
  • Funds reported $2.9K of Infinity Pharmaceuticals, Inc. stock for Q3 2023, down 100% quarter-over-quarter.
  • 2 funds opened new Infinity Pharmaceuticals, Inc. positions in Q3 2023 and 44 closed out, a net change of -42 holders.
  • The largest Infinity Pharmaceuticals, Inc. buyer in Q3 2023 was XTX Topco, an estimated $24K added.
  • The largest Infinity Pharmaceuticals, Inc. seller in Q3 2023 was BVF Inc, an estimated $1.34M sold.

Based on aggregated 13F filings for Q3 2023.